Best-in-class bank, trading at twice its long-run multiple — with no margin of safety left.

• The franchise is real. 26.9% return on tangible common equity for FY25, the third straight year above 25%; cost-income 36.1%, NPL 0.8%, CET1 14.6% pro-forma. Every quality metric sits in the European top decile.
• The price is full. 2.91× tangible book versus a seven-year average of 1.45×. The premium is paid for through-cycle RoTCE staying above 22% — any single quarter under that mechanically resets the multiple toward 2.0× (~$130).
• Q1 2026 was the first clean miss since 2023. Pretax $360M vs $379M consensus; provisions ran $9M hot at $75M, annualising to $299M — above FY25's $268M full-year. The first crack landed the same week as the largest deal in BAWAG's history.

The 15th deal is a step-change — and it spent the M&A optionality the multiple priced in.

• $1.86B all-cash for Ireland's #3 bank, announced 14 April 2026. Permanent TSB carries a $35.1B balance sheet — larger than the prior fourteen deals combined. 26% premium; H1 2026 dividend paused; closing targeted Q1 2027.
• ~450 bps of CET1 consumed — essentially all of it. Pre-deal excess capital was $550M; PTSB takes the lot. The funding bridge depends on synthetic risk transfers, not surplus capital, and the 16th deal at the 20% hurdle becomes harder, not easier.
• Run through a partly-new board. PTSB's 70% cost-income ratio has to be halved toward AIB's 44% benchmark, in a market where AIB and BIRG already control 60%+ of mortgages — and the Supervisory Board overseeing it has five of eight members who first sat down in April–May 2025.

Consensus FY26 is anchored on a reserve-flattered base.

Management's own FY25 disclosure states verbatim that "in the prior year a management overlay was released" — meaning the FY24 $790M base every sell-side model walks from was below run-rate. If risk costs settle at the FY25 41 bps and AT1 coupon steps to $70–82M as guided, unsmoothed FY26 net profit lands $970M–$1.03B — 8–14% below the >$1.12B consensus, before a single PTSB line item. The book today: 11 Buys, 2 Holds, 0 Sells, $194 average target.

Same six people for nine years, mandates locked through 2029, $613M of personally-paid-for stock.

• 14 deals, 14 hurdles cleared. Every acquisition since 2015 has met the 20% RoTCE hurdle on management's own scorecard. Knab and easybank Germany are integrating ahead of plan. Only KBC and ING are comparable cross-border consolidators in Europe.
• Skin in the game is real. The Management Board owns $613M of stock — 74% of it bought with personal cash. CEO Anas Abuzaakouk holds $192M in shares he paid for, on top of grants. Zero open-market sells by any board member in 2025.
• CEO took a 25% fixed-pay cut after a soft say-on-pay vote. Combined board STI cash dropped from $21.7M to $8.9M in a record-profit year; the variable balance shifted to share-based with multi-year deferral. Share count down 23% since the 2017 IPO.

Two events between July and September resolve the active debate.

• July 21 — Q2 results. First quarterly print after the Q1 miss. Risk costs above $82M confirms the bear thesis and forces FY26 estimate cuts; risk costs under $70M with net interest margin holding at 3.25% kills the consumer-credit normalisation story outright.
• Summer 2026 — PTSB Scheme Meeting and EGM. Court-sanctioned vote at $3.42 cash. The Irish State holds 57.5% and is committed, but a minority sweetener — Carraighill has already called the deal "of a lifetime" for BAWAG — would reset the IRR the rerating relies on.
• Four ECB decisions through October. Net interest income is now 83% of operating revenue — the most rate-sensitive bank in the peer set. Markets are flirting with hikes after the April hold; a hold-or-hawkish-hold path breaks the bear's "rate cycle reversing" leg.